Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy ; volume:6 ; number:3 ; year:2020 ; pages:168-180
Kidney diseases ; 6, Heft 3 (2020), 168-180
- Creator
-
Yamada, Koshi
Huang, Zhi qiang
Raska, Milan
Reily, Colin
Anderson, Joshua C.
Suzuki, Hitoshi
Kiryluk, Krzysztof
Gharavi, Ali G.
Julian, Bruce A.
Willey, Christopher D.
Novak, Jan
- DOI
-
10.1159/000505748
- URN
-
urn:nbn:de:101:1-2020060400005765532302
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yamada, Koshi
- Huang, Zhi qiang
- Raska, Milan
- Reily, Colin
- Anderson, Joshua C.
- Suzuki, Hitoshi
- Kiryluk, Krzysztof
- Gharavi, Ali G.
- Julian, Bruce A.
- Willey, Christopher D.
- Novak, Jan
Other Objects (12)
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
IgA nephropathy today : 10 tables
Complement activation in IgA nephropathy
Current treatment of IgA nephropathy
IgA Nephropathy: A Chinese Perspective
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
IgA nephropathy today : 10 tables
Complement activation in IgA nephropathy
Current treatment of IgA nephropathy
IgA Nephropathy: A Chinese Perspective
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
IgA nephropathy today : 10 tables
Complement activation in IgA nephropathy
Current treatment of IgA nephropathy